You Are Here: Home > Cancer Research > Drug Development

Drug / Device Development

If you are reading this section as an e-Training course, please read the
e-Training Quiz Introduction first and then return here.

Overview

This content has been reviewed by the National Cancer Institute for accuracy and completeness.

Drug development begins with an idea and moves through the entire research process beginning with basic research, moving into translational (preclinical) studies, and finally resulting in a clinical trial. Then the drug must navigate through the regulatory process. This section provides a big picture snapshot about this process, including information about the economics and the various stakeholders.

 

In this section we will discuss:

 

 

 



 
Personalized Medicine
 
Recently Diagnosed
 
Cancer 101
 
Survivorship
 
Research
Advocacy
 
Inspiration
 
Resources
 
Webinars
 
e-Training
 
Latina Navigator Training
 
 
 
 
 
 
 

 

 

 

 

 
   
 
 
Site Design by: Cara M. Caloroso
 
CISN Home Page About Us Services CISN Home Page Contact Site Map CISN Home Page CISN Home Page